InsiderSignalSign in

← Insider buys

TXMD

TherapeuticsMD, Inc. · Healthcare

No insider bought or sold TherapeuticsMD, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

$23.4MMarket cap

TXMD over the last year

No insider buys filed in this year

TXMD after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

52 insider filings since 2017, newest first

Marlan D Walker · CEO

$44K−23.0%Dec 7

Rubric Capital Management LP · 10% owner

$38.7M−100.0%Jan 3

Rubric Capital Management LP · 10% owner

$90K+1.0%Dec 12

Rubric Capital Management LP · 10% owner

$116K+1.0%Dec 9

Rubric Capital Management LP · 10% owner

$15.0M+50.0%Aug 1

Rubric Capital Management LP · 10% owner

$467K+4.0%Jul 19

Cooper C. Collins · Director

$579K+81.0%Nov 22

Karen Ling · Director

$25K+35.0%Aug 19

Cooper C. Collins · Director

$725K+422.0%Aug 19

Paul Bisaro · Director

$40K+34.0%Aug 18

James Darecca · CFO

$81K−43.0%Aug 12

Edward Borkowski · EVP, Operations

$46K−43.0%May 12

John C.k. Milligan IV · Secretary, CEO of subsidiary

$46K−1.0%May 12

Robert G Finizio · CEO

Mitchell Krassan · Chief Strategy Officer

$677K−100.0%Feb 5

Brian Bernick · Director

$99K+1.0%Oct 29

Robert G Finizio · CEO

John C.k. Milligan IV · President and Secretary

$198K+1.0%Oct 29

Angus C. Russell · Director

$99K+72.0%Aug 15

John C.k. Milligan IV · President and Secretary

Brian Bernick · Director

Robert G Finizio · CEO

Cooper C. Collins · Director

$100K+83.0%May 15

Jules A. Musing · Director

$101K−78.0%Mar 1

Robert G Finizio · CEO

$677K−1.0%Dec 21

John C.k. Milligan IV · President and Secretary

$953K−5.0%Dec 19

Brian Bernick · Director

$761K−3.0%Dec 14

Robert G Finizio · CEO

$844K−1.0%Dec 10

Daniel A Cartwright · CFO

$183K−50.0%Dec 10

John C.k. Milligan IV · President and Secretary

$1.2M−5.0%Dec 6

Brian Bernick · Director

$927K−3.0%Dec 4

John C.k. Milligan IV · President and Secretary

$1.3M−5.0%Nov 30

Robert G Finizio · CEO

$889K−1.0%Nov 28

Brian Bernick · Director

$867K−3.0%Nov 21

John C.k. Milligan IV · President and Secretary

$1.3M−5.0%Nov 16

Robert G Finizio · CEO

$878K−1.0%Nov 14

Brian Bernick · Director

$891K−3.0%Nov 13

Daniel A Cartwright · CFO

$194K−100.0%Nov 13

Robert G Finizio · CEO

$972K−1.0%Oct 29

John C.k. Milligan IV · President and Secretary

$1.3M−4.0%Oct 25

Brian Bernick · Director

$1.0M−3.0%Oct 22

Robert G Finizio · CEO

$1.0M−1.0%Oct 15

John C.k. Milligan IV · President and Secretary

$1.5M−4.0%Oct 11

Brian Bernick · Director

$1.1M−3.0%Oct 9

Brian Bernick · Director

$1.2M−3.0%Oct 1

John C.k. Milligan IV · President and Secretary

$1.7M−4.0%Sep 27

Robert G Finizio · CEO and 10% owner

$1.2M−1.0%Sep 24

Brian Bernick · Director

$1.2M−3.0%Sep 14

John C.k. Milligan IV · President and Secretary

$1.5M−4.0%Sep 12

Robert G Finizio · CEO and 10% owner

$1.1M−1.0%Sep 10

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.